4
Changes in Ownership
Invivyd, Inc. Filed Acc 0000950170-25-110339
Chief Scientific Officer sold 45,932 shares at an average $0.60 ($27,573)
- Chief Scientific Officer acquired 99,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Allen Robert D. III · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +99,000 | 99,000 | D | ||
| 2025-08-18 | Sale : show line 2 in the form 10b5-1 | −18,512 | $0.65 | $12,037 | 80,488 | D |
| 2025-08-19 | Sale : show line 3 in the form 10b5-1 | −27,420 | $0.57 | $15,536 | 53,068 | D |
| Open-market sales · 45,932 sh · avg $0.60 · $27,573 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-15 | Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units | −99,000 | 201,000 | D |
Loading xslF345X05/ownership.xml…